Skip to main content
INCY
NASDAQ Life Sciences

欧盟委员会支持Olumiant用于青少年斑秃，利好Incyte

feedReported by Dow Jones Newswires
Sentiment info
Positive
Importance info
7
Price
$98.92
Mkt Cap
$19.919B
52W Low
$53.56
52W High
$112.29
Market data snapshot near publication time

summarizeSummary

Incyte和Eli Lilly的Olumiant获得了欧洲药品管理局药品人类使用委员会（CHMP）的积极推荐，用于扩大批准用于12岁及以上严重斑秃的青少年。这一重大监管里程碑是在成年人现有批准之后，扩大了Olumiant在欧洲的潜在市场。CHMP的支持是欧盟委员会全面的批准的强烈指标，通常在一个或两个月内授予。这一发展是Incyte的一个重要的积极因素，考虑到Olumiant对其产品组合的重要性，也使合作伙伴Eli Lilly受益。

在该公告发布时，INCY的交易价格为$98.92，交易所为NASDAQ，所属行业为Life Sciences，市值约为$199.2亿。 52周交易区间为$53.56至$112.29。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed INCY - Latest Insights

INCY
Apr 28, 2026, 4:25 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Incyte Details Strong 2025 Performance, Robust Pipeline, and Annual Meeting Proposals
Sentiment: Positive
View Wiseek Article
INCY
Apr 28, 2026, 4:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Incyte Reports Strong Q1 2026 Financials, Major Pipeline Progress, and Appoints New CFO
Sentiment: Positive
View Wiseek Article
INCY
Apr 28, 2026, 7:03 AM EDT
Filing Type: 8-K
Importance Score:
8
Incyte Reports Strong Q1 2026 Financial Results with 21% Revenue Growth and Positive Povorcitinib Phase 3 Data
Sentiment: Positive
View Wiseek Article
INCY
Mar 28, 2026, 3:00 PM EDT
Source: Reuters
Importance Score:
9
Incyte's Oral Skin Drug Povorcitinib Delivers Strong Long-Term Symptom Relief in Late-Stage Trials
Sentiment: Positive
View Wiseek Article
INCY
Mar 26, 2026, 8:38 AM EDT
Filing Type: 8-K
Importance Score:
7
Incyte Reorganizes Executive Leadership for Strategic Growth
Sentiment: Neutral
View Wiseek Article
INCY
Mar 06, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
7
FDA Issues Complete Response Letter for Zynyz in NSCLC Due to Manufacturing Site Issues
Sentiment: Negative
View Wiseek Article
INCY
Mar 06, 2026, 4:56 PM EST
Source: Reuters
Importance Score:
8
European Commission Approves Incyte's Zynyz for First-Line Advanced Anal Canal Cancer
Sentiment: Positive
View Wiseek Article
INCY
Feb 27, 2026, 9:23 AM EST
Source: Dow Jones Newswires
Importance Score:
7
EU Committee Backs Olumiant for Adolescent Alopecia Areata, Positive for Incyte
Sentiment: Positive
View Wiseek Article
INCY
Feb 10, 2026, 6:31 PM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Major Investor Baker Bros. Secures Rights to Sell 15.3% Stake in Incyte
Sentiment: Negative
View Wiseek Article
INCY
Feb 10, 2026, 4:01 PM EST
Filing Type: 10-K
Importance Score:
9
Incyte Reports Strong 2025 Financials, Major Pipeline Wins & Favorable Novartis Settlement
Sentiment: Positive
View Wiseek Article